24 Mar 2021 Enterome Receives FDA IND Clearance for EO2463, an 'OncoMimic' based Immunotherapy Targeting Liquid Tumors
24 Mar 2021 Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate
23 Mar 2021 Precigen Announces First Patient Dosed for PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)
23 Mar 2021 Anokion Initiates Patient Dosing in Phase 1 Trial of ANK-700 for the Treatment of Multiple Sclerosis
22 Mar 2021 Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants
22 Mar 2021 Consortium led by eTheRNA immunotherapies Awarded EU Commission TIGER Grant of EUR 6.9 million
22 Mar 2021 AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis
22 Mar 2021 Daiichi Sankyo Initiates Phase 1/2 Clinical Trial for mRNA COVID-19 vaccine in Japan
20 Mar 2021 Premas Biotech and Oramed Announce Oral COVID-19 Vaccine Candidate That Produces Antibodies After a Single Dose
19 Mar 2021 BlueSky Immunotherapies GmbH (Ltd.): Phase 1 clinical trial for delNS HPV 16
18 Mar 2021 First Participants Dosed in Phase 1 Study Evaluating mRNA-1283, Moderna’s Next Generation COVID-19 Vaccine
18 Mar 2021 Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Pediatric Population
16 Mar 2021 AC Immune Announces New Clinical Results in Down Syndrome and Plans for Future Development of Anti-Amyloid-Beta Vaccine
16 Mar 2021 Medicago and GSK Start Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate
16 Mar 2021 Meissa Announces IND Clearance for Phase 1 Study of Intranasal Live Attenuated Vaccine Candidate for COVID-19
15 Mar 2021 Update on the safety of COVID-19 Vaccine AstraZeneca
12 Mar 2021 Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate
12 Mar 2021 Nouscom receives approval to begin Phase 1b trials of NOUS-PEV, a novel personalized cancer immunotherapy
12 Mar 2021 Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Conditional Marketing Authorization by European Commission
11 Mar 2021 AELIX Therapeutics presents positive results from randomized placebo-controlled phase I/IIa therapeutic HIV vaccine clinical trial
11 Mar 2021 Moderna Announces First Participants Dosed in Study Evaluating COVID-19 Booster Vaccine Candidates
09 Mar 2021 Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-in-Human Trial
09 Mar 2021 Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate
04 Mar 2021 Geneos Therapeutics Secures $12 Million in Series A1 Financing to Advance Personalized Cancer Immunotherapy Programs
04 Mar 2021 ConserV Bioscience and eTheRNA immunotherapies to Collaborate on Development of mRNA Vaccines for Infectious Diseases

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up